Peter Ceuppens

Biostatistical Methodology in Carcinogenicity Studies

William R. Fairweather, Amit Bhattacharyya, Peter Ceuppens et al. · Drug Information Journal · 1998 · 27 citations · Full text

Biostatistical Methodology, Cancer Epidemiology, Malignant Disease +4

Determination of the safety and efficacy of therapeutic neutralization of tumor necrosis factor-α (TNF-α) using AZD9773, an anti-TNF-α immune Fab, in murine CLP sepsis

Peter Newham, Daniel W. Ross, Peter Ceuppens et al. · Inflammation Research · 2013 · 20 citations · Full text

Inflammation, Cytokine, Medicine +14

¹⁷⁷Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma

Marion Masitsa Malenge, Sebastian Patzke, Anne Hansen Ree et al. · Journal of Nuclear Medicine · 2020 · 12 citations · Full text

Social-housing and use of double-decker cages in rat telemetry studies

Matthew Skinner, Peter Ceuppens, Peter A. White et al. · Journal of Pharmacological and Toxicological Methods · 2019 · 11 citations

Rodent Management, Double-decker Cages, Telehealth

ARMS™ Allele-specific Amplification-based Detection of Mutant p53 DNA and mRNA in Tumors of the Breast

Darren Hodgson, Simon J. Clayton, Fiona Girdler et al. · Clinical Chemistry · 2001 · 10 citations · Full text

Mutant P53 Dna, Breast Oncology, Allele-specific Amplification-based Detection +21